Treatment of Acute Thiamine Deficiency
For adults with suspected acute thiamine deficiency presenting with confusion, ataxia, ophthalmoplegia, peripheral neuropathy, or beriberi, immediately administer high-dose intravenous thiamine without waiting for laboratory confirmation—the specific dose depends on clinical severity, ranging from 200 mg three times daily for high suspicion to 500 mg three times daily for encephalopathy. 1
Dosing Algorithm Based on Clinical Presentation
The 2022 ESPEN guidelines provide clear, severity-stratified dosing recommendations 1:
Severe Presentations (Neurological Emergency)
- Encephalopathy of uncertain etiology (including Wernicke encephalopathy): 500 mg IV three times daily
- Confusion, ataxia, ophthalmoplegia: This constitutes encephalopathy—use 500 mg IV TID
High Suspicion or Proven Deficiency
- Peripheral neuropathy with risk factors: 200 mg IV three times daily
- Beriberi (wet or dry): 200 mg IV three times daily
At Risk Without Overt Symptoms
- Malnutrition, chronic alcohol use, recent poor intake: 100 mg IV three times daily
Critical Implementation Points
Use the IV route for any acute presentation. Even though thiamine is generally well absorbed orally, patients with chronic alcohol use have impaired gastrointestinal absorption, and acute illness demands rapid tissue saturation 1. The guideline explicitly states that in acute disease with suspected inadequate intake, the IV route should be used.
Do not delay treatment for laboratory confirmation. Thiamine reserves deplete within 20 days of inadequate intake, and the consequences of untreated deficiency (20% mortality in Wernicke-Korsakoff syndrome, permanent neurological damage) far outweigh the minimal risks of treatment 1, 2. The risk of anaphylaxis from IV thiamine is less than 1 in 100,000 2.
Duration: Continue high-dose IV thiamine for 3-4 days, then transition to maintenance dosing of 50-100 mg daily orally once acute symptoms resolve 1.
Why These Doses Matter
The guideline emphasizes that due to poor absorption in at-risk patients (particularly those with alcohol use or gastrointestinal disease), IV thiamine at 250 mg or higher is required to manage encephalopathy 1. Lower doses used historically have proven inadequate for reversing acute neurological manifestations.
Clinical improvement can occur within hours to days with appropriate dosing 3. Neurological symptoms may require higher doses and longer recovery time than cardiovascular manifestations, but rapid response to treatment is characteristic and helps confirm the diagnosis 4, 5.
Common Pitfalls to Avoid
Don't substitute oral thiamine in acute presentations. Malabsorption is common in at-risk patients, and oral supplementation alone is inadequate for emergencies 6, 7.
Don't underdose. Historical regimens using 50-100 mg daily are insufficient for treating acute encephalopathy—this is a maintenance dose, not a treatment dose 1.
Don't miss concurrent refeeding syndrome risk. If the patient requires nutritional support, give 300 mg IV thiamine before initiating nutrition therapy, then 200-300 mg IV daily for at least 3 more days 1.
Safety Profile
Thiamine has no established upper limit for toxicity 1. Excess is simply excreted in urine. The only documented adverse effects are rare anaphylaxis (extremely uncommon) and mild gastrointestinal symptoms or ataxia with doses exceeding 400 mg 1. The risk of undertreating vastly exceeds the risk of overtreating.
Maintenance After Acute Phase
Once acute symptoms stabilize (typically 3-4 days), transition to oral maintenance: 50-100 mg daily, continuing for at least 6 weeks to replete body stores 1. Address underlying causes (malnutrition, alcohol use, malabsorption) to prevent recurrence.